Andrea D'Alessio

Vita-Salute San Raffaele University

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Armando Santoro

Professore

Humanitas University

ITALY

View details

Monica Bocchia

University of Siena

ITALY

View details

Cinzia Giaccherini

Aziende Socio Sanitarie Territoriale Papa Giovanni XXIII

ITALY

View details

Filippo Guglielmo Maria de Braud

Professor

Università di Milano

ITALY

View details

Anna Falanga

Full Professor of Hematology

University of Milano-Bicocca

ITALY

View details

Sara Gamba

Biologo libero professionista

Ospedale Pediatrico Bambino Gesù

ITALY

View details

Carin C.D. Van der Rijt

Full professor

Erasmus University Rotterdam

NETHERLANDS

View details

Grigoris Gerotziafas

Sorbonne Université

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea D'Alessio

Research Interests

Explore related searches

Contact this professor

Articles (10)

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients

The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis

Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.

Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer

Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients

Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients

JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy

Surveillance for hepatocellular carcinoma at the community level: Easier said than done

JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy

Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.

Collaborators (8)

Armando Santoro

Monica Bocchia

Cinzia Giaccherini

Filippo Guglielmo Maria de Braud

Anna Falanga

Sara Gamba

Carin C.D. Van der Rijt

Grigoris Gerotziafas

Make your next move.